Hormone-Refractory Prostate Cancer Completed Phase 3 Trials for Prednisone (DB00635)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00069745Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy RegimenTreatment